LifeMD Delays Third-Quarter Report to Correct Accounting Errors
- LifeMD delayed its Form 10-Q for the quarter ended September 30, 2026, beyond the November 9, 2026, deadline.
- The filing is expected within five calendar days of the original deadline.
- Additional time is needed to correct overstated revenue and understated expenses in quarterly and annual financial statements from 2024 through June 30, 2026.
- The corrections will not affect cash flow or cash position.
- Management is evaluating the potential impact on disclosure controls and internal control over financial reporting.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LifeMD Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-050637), on November 09, 2026, and is solely responsible for the information contained therein.